Barinthus Biotherapeutics PLBRNS
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 14 institutions reported holding Barinthus Biotherapeutics PL (BRNS) in their 13F filings, down 1 from Q1 2025. 0 opened new positions and 1 sold out. The largest holders were M&G PLC ($5.2M), Alphabet Inc. ($1.4M) and HSG Holding Ltd ($1.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Barinthus Biotherapeutics PL
- CUSIP
- 91864C107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 104,581 shares bought and 280,427 shares sold, net −175,846 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| M&G PLC | 0.03% | No change | 5,197,349 | $5.2M |
| Alphabet Inc. | 0.07% | No change | 1,513,644 | $1.4M |
| HSG Holding Ltd | 0.07% | No change | 1,420,473 | $1.3M |
| DC Funds, LP | 27.74% | No change | 642,204 | $597K |
| Baird Financial Group, Inc. | 0.00% | Add +108.2% | 192,461 | $179K |
| Johns Hopkins University | 0.01% | No change | 122,237 | $114K |
| Gilead Sciences, Inc. | 0.01% | Reduce -73.1% | 99,478 | $93K |
| HighTower Advisors, LLC | 0.00% | No change | 37,450 | $35K |
| Renaissance Technologies | 0.00% | Add +1.7% | 36,300 | $34K |
| Citadel Advisors | 0.00% | Reduce -38.0% | 16,227 | $15K |
| Janney Montgomery Scott LLC | 0.00% | No change | 15,373 | $14K |
| Geode Capital Management, LLC | 0.00% | No change | 11,568 | $11K |
| Morgan Stanley | 0.00% | Add +457.1% | 4,852 | $5K |
| New England Capital Financial Advisors LLC | 0.00% | No change | 45 | $42 |
"% of holder's portfolio" is BRNS's weight in each manager's 13F, not the share of Barinthus Biotherapeutics PL the manager owns.